PMID: 2108937Apr 1, 1990Paper

The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients

International Journal of Radiation Oncology, Biology, Physics
J GlaholmJ H Crow

Abstract

One hundred and eighty-six patients with intracranial meningiomas were treated at the Royal Marsden Hospital between 1963 and 1983 with megavoltage photon irradiation (60Co gamma rays and 6-8 Mv. X rays). Survival parameters were measured from the time of referral for radiotherapy. The 10-year actuarial cause-specific survival was 67% for all cases and the actuarial disease-free survival was 61%. Both malignant and also "aggressive benign" histologies were associated with poor long-term survival. Benign angioblastic meningioma was associated with lower actuarial cause specific and disease-free survival compared with other benign histological sub-groups. Prognosis was related to the extent of initial surgical resection. Of those who underwent subtotal or partial tumor resection with post-operative radiotherapy the 10-year actuarial cause-specific survival was 77%, and in inoperable patients treated by radiotherapy alone it was 46%. Radiotherapy alone resulted in improvement of neurological performance (Karnofsky) in 12 out of the 32 (38%) patients with inoperable disease. The 10-year survival of patients referred for irradiation following "complete" surgical resection was only 34% owing to the high incidence of adverse histologi...Continue Reading

References

Mar 1, 1975·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·W M WaraE B Boldrey
Aug 1, 1986·American Journal of Clinical Oncology·J B MesicR L Doggett
Apr 1, 1985·International Journal of Radiation Oncology, Biology, Physics·M J Solan, S Kramer
Nov 1, 1984·Journal of Neurosurgery·A B RubinsteinE Reichenthal
Mar 1, 1981·International Journal of Radiation Oncology, Biology, Physics·R D Pezner, J O Archambeau

❮ Previous
Next ❯

Citations

Sep 1, 1996·Journal of Neuro-oncology·M H Maor
Jan 1, 1994·Journal of Neuro-oncology·R Desai, J Bruce
Oct 1, 1995·Journal of Neuro-oncology·R M LinggoodF S Pardo
Oct 29, 2004·Current Treatment Options in Oncology·Kevin P McMullen, Volker W Stieber
Sep 30, 1995·International Journal of Radiation Oncology, Biology, Physics·J P MaireM Dautheribes
Mar 1, 1996·International Journal of Radiation Oncology, Biology, Physics·M F MilosevicW J Simpson
Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Stefanie Milker-ZabelJürgen Debus
Apr 7, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Serdar SoyuerFranco DeMonte
Nov 1, 1993·Mayo Clinic Proceedings·D H Char
Aug 19, 2003·Surgical Neurology·Tiit MathiesenChrister Lindquist
Oct 2, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·N PourelP Bey
Jun 15, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·H AlheitM Brada
Dec 21, 2000·International Journal of Radiation Oncology, Biology, Physics·E WenkelJ E Munzenrider
Jul 4, 2002·International Journal of Radiation Oncology, Biology, Physics·Antonio NicolatoMassimo Gerosa
Jul 20, 2002·International Journal of Radiation Oncology, Biology, Physics·Nathan W UyE Brian Butler
Jan 16, 2003·International Journal of Radiation Oncology, Biology, Physics·Andrea PirzkallM Wannenmacher
Jun 1, 1997·International Journal of Radiation Oncology, Biology, Physics·K T ColvettF S Pardo
Oct 6, 1997·International Journal of Radiation Oncology, Biology, Physics·K S CondraA L Rhoton
Feb 25, 1999·International Journal of Radiation Oncology, Biology, Physics·D H ShafronW M Mendenhall
Apr 29, 1999·International Journal of Radiation Oncology, Biology, Physics·P D MaguireE C Halperin
Feb 3, 2000·International Journal of Radiation Oncology, Biology, Physics·L K GoyalG H Barnett
Mar 13, 2012·Neuro-oncology·Hanna van AlkemadeLukas J A Stalpers
Sep 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·W KreilG Papaefthymiou
Jun 8, 2011·Journal of Hematology & Oncology·Anand VeeravaguSteven D Chang
Aug 13, 2013·Journal of Neurosurgery·Dale DingJason P Sheehan
Oct 27, 2007·Neurosurgical Focus·Leland Rogers, Minesh Mehta
Oct 27, 2007·Neurosurgical Focus·Andrew E H EliaJay S Loeffler
Jan 27, 2005·Neurosurgical Focus·Steven D Chang, Gordon T Sakamoto
Jan 27, 2005·Neurosurgical Focus·Rodrigo Couto TorresMichael Selch
Oct 17, 2007·Journal of Neurosurgery·Toshinori HasegawaDai Ishii
Oct 1, 1992·Journal of Neurosurgery·J M MarkertR L Martuza
Feb 1, 1994·Journal of Neurosurgery·S A Newman
Feb 1, 1994·Journal of Neurosurgery·J C MaroonL Sternau
May 1, 1996·Journal of Neurosurgery·M C Chamberlain
May 1, 1999·Journal of Neurosurgery·C NuttingS Ashley
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·Gerd BeckerMichael Bamberg
Mar 22, 2014·Radiation Oncology·David KaulHarun Badakhshi
Jan 1, 1993·Acta neurochirurgica·V ValentinoA J Raimondi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
B W TaylorR R Million
International Journal of Radiation Oncology, Biology, Physics
R EngenhartM Wannenmacher
International Journal of Radiation Oncology, Biology, Physics
K S CondraA L Rhoton
© 2021 Meta ULC. All rights reserved